Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
4.
Dermatol Ther ; 35(9): e15691, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35790062

RESUMEN

Hidradenitis suppurativa (HS) is a chronic inflammatory often recalcitrant to treatment. There is a lack of an updated systematic data review for infliximab use in HS. We conducted a systematic review and meta-analysis of literature on infliximab in HS. This study was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was pre-registered on PROSPERO (CRD42021283596). In 9/2021, MEDLINE and EMBASE were systematically searched for articles on infliximab in HS. Non-English, duplicate, and studies with <5 HS patients were excluded. Study quality was assessed utilizing Cochrane Risk of Bias for prospective trials and Newcastle-Ottawa Scale for cohort studies. Random effects meta-analytical model, Cochran's Q statistic, and I squared index were performed. Nineteen articles (314 patients) met inclusion criteria (six prospective, 13 retrospective studies). All patients with HS severity data available (n = 299) had moderate-to-severe disease. Outcome measures used for meta-analysis of the pooled response rate were largely based on clinician reported outcomes (16 studies). One utilized both clinician and patient assessment. Two utilized patient-reported response alone. The pooled response rate of HS patients to infliximab was 83% (95% CI, 0.71-0.91). The most common adverse events (AEs) included non-serious infections (13.2%) and infusion reaction (2.9%). The rate of serious AEs was 2.9%. Study limitations include the small number of prospective studies and heterogeneity between studies. Overall, infliximab is an effective treatment for moderate-to-severe HS. Efficacy of infliximab in HS should be compared to other biologics in larger, randomized controlled trials.


Asunto(s)
Hidradenitis Supurativa , Anticuerpos Monoclonales/efectos adversos , Hidradenitis Supurativa/inducido químicamente , Hidradenitis Supurativa/tratamiento farmacológico , Humanos , Infliximab/efectos adversos , Estudios Prospectivos , Estudios Retrospectivos
5.
Dermatol Ther ; 35(1): e15210, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34796606

RESUMEN

Hyperhidrosis impairs quality of life (QOL) in hidradenitis suppurativa (HS) patients and may exacerbate HS. However, there is limited literature on whether hyperhidrosis treatments improve HS disease. To systematically review literature on efficacy and tolerability of hyperhidrosis treatments in HS patients. In May 2021, MEDLINE and EMBASE databases were systematically searched by two reviewers per PRISMA guidelines for articles on hyperhidrosis and HS. Sixteen articles met inclusion criteria (2 randomized controlled trials [RCTs], one case-control study, three cross-sectional studies, 10 case-studies/series), encompassing 252 HS patients across studies. They examined botulinum toxin A (BTX-A) (n = 6) and B (BTX-B) (n = 1), suction-curettage (n = 1), diode laser (n = 1), and microwave-based energy device (MED) (n = 3). Overall, BTX treatments improve HS severity, QOL, hyperhidrosis, and were well-tolerated. Suction-curettage did not improve disease. One HS patient tolerated diode laser well, with improvement in sweating and HS. One RCT studying MED was discontinued due to adverse events. Two studies reported MED-induced HS. BTX was overall helpful in HS patients, including in patients without concomitant hyperhidrosis. However, more prospective studies are needed to examine its utility in HS. There is potential harm of MEDs in HS. Most studies examining hyperhidrosis treatments in HS patients are low level of evidence. Larger RCTs should examine the efficacy and tolerability of hyperhidrosis treatments in HS.


Asunto(s)
Toxinas Botulínicas Tipo A , Hidradenitis Supurativa , Hiperhidrosis , Toxinas Botulínicas Tipo A/efectos adversos , Toxinas Botulínicas Tipo A/uso terapéutico , Estudios de Casos y Controles , Hidradenitis Supurativa/complicaciones , Hidradenitis Supurativa/diagnóstico , Hidradenitis Supurativa/terapia , Humanos , Hiperhidrosis/diagnóstico , Hiperhidrosis/etiología , Hiperhidrosis/terapia , Calidad de Vida
6.
Int J Dermatol ; 59(7): 770-786, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31904115

RESUMEN

IMPORTANCE: Erosive pustular dermatosis (EPD) is a rare chronic inflammatory condition of the scalp and legs that is often difficult to manage. Currently, there are no treatment guidelines. OBJECTIVE: To systematically assess the existing literature on various treatment modalities and their efficacies when used in the management of EPD. EVIDENCE REVIEW: We searched PubMed, Cochrane Libraries, Scopus, and clicnialtrial.gov databases for articles in the English language with no limited time frame. Emphasis was placed on articles that reported on treatment for EPD. FINDINGS: Of the 168 articles identified by the literature search, 92 met eligibility criteria and were included for qualitative analysis. Efficacious topical treatments included clobetasol, betamethasone, and tacrolimus. Ninety-three and 88% of cases utilizing clobetasol and betamethasone respectively demonstrated improvement or resolution. All 32 cases utilizing tacrolimus reported improvement. Efficacious systemic treatments included oral steroids such as prednisone, methylprednisolone, and dexamethasone. Topical dapsone, photodynamic therapy, systemic steroids, cyclosporine, and oral zinc derivatives were also described with some success. CONCLUSIONS AND RELEVANCE: According to available data, limited solely to case reports and case series, potent topical steroids are an effective treatment option for EPD. Topical tacrolimus may also be considered in cases that require long-term use or maintenance. Other treatment modalities shown to be successful based on high reported efficacy and low rates of recurrence after treatment include topical dapsone, systemic steroids, zinc derivatives, and cyclosporine. Further studies are needed to compare treatment modalities and to establish treatment protocols.


Asunto(s)
Inhibidores de la Calcineurina/uso terapéutico , Glucocorticoides/uso terapéutico , Dermatosis de la Pierna/tratamiento farmacológico , Fotoquimioterapia , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Tacrolimus/uso terapéutico , Administración Cutánea , Administración Oral , Antiinfecciosos/uso terapéutico , Betametasona/uso terapéutico , Inhibidores de la Calcineurina/administración & dosificación , Clobetasol/uso terapéutico , Dapsona/uso terapéutico , Dexametasona/uso terapéutico , Glucocorticoides/administración & dosificación , Humanos , Metilprednisolona/uso terapéutico , Tacrolimus/administración & dosificación
10.
Int Health ; 10(5): 401-403, 2018 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-29897586

RESUMEN

Background: Young people living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) (PLWA) are at risk for HIV stigma. Methods: The HIV/AIDS Stigma Instrument for PLWA was administered to 36 young PLWA across six clinics in Bandung, Indonesia, to assess the fear of contagion (FC), verbal abuse (VA), social isolation (SI), workplace stigma (WS), health care neglect (HCN) and negative self-perception (NSP). Results: The median scores for FC, VA, SI, WS and HCN were all 0 while the median score for NSP was 4. In the last 3 months approximately 45% of surveyed PLWA felt they did not deserve to live and 64% felt completely worthless. Conclusions: While these results are preliminary, access to mental health services should be a priority in the clinics that provide antiretroviral therapies.


Asunto(s)
Infecciones por VIH/psicología , Autoimagen , Estigma Social , Estereotipo , Adulto , Femenino , Humanos , Indonesia , Masculino , Prejuicio , Autorrevelación , Adulto Joven
11.
World J Emerg Med ; 8(4): 281-286, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29123606

RESUMEN

BACKGROUND: The purpose of this study was to assess the short-term efficacy of a 4-week ultrasound curriculum taught by American first-year medical students to general practitioners working in public health care clinics, or puskesmas, in Bandung, Indonesia. METHODS: We performed a prospective, observational study of Indonesian health care practitioners from public clinics in Bandung, Indonesia. These practitioners were enrolled in a 4-week ultrasound training course taught by first-year American medical students. A total of six sessions were held comprising of 38 ultrasound milestones. A pre-course and post-course written exam and practical exam was taken by each participant. RESULTS: We enrolled 41 clinicians in the course. The average pre-course exam score was 35.2% with a 2.4% pass rate, whereas the average post-course exam score was 82.0% with a 92.7% pass rate. The average practical score at the completion of the course was 83.2% (SD=0.145) with 82.9% of the class passing (score above 75.0%). CONCLUSION: Our data suggests that first-year medical students can effectively teach ultrasound to physicians in Indonesia using a 4-week intensive ultrasound training course. Future studies are needed to determine the amount of training required for proficiency and to evaluate the physicians' perceptions of the student-instructors' depth of knowledge and skill in point of care ultrasound.

12.
World J Emerg Med ; 8(3): 177-183, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28680513

RESUMEN

BACKGROUND: The purpose of this study was to use point-of-care ultrasound (POCUS) to investigate the relationship between tobacco smoke exposure and the characteristics of the common carotid artery (CCA). The effect of both primary and secondary smoking on CCA properties was evaluated. METHODS: We performed a prospective cross-sectional study across 20 primary care clinics in Bandung, West Java, Indonesia in July 2016. Point of care ultrasound was performed on a convenience sample of Indonesian patients presenting to clinic. The CCA wall stiffness and carotid intima-media thickness (CIMT) were measured during diastole and systole. These measurements were correlated with smoke exposure and cardiovascular disease. RESULTS: We enrolled 663 patients in the study, with 426 patients enrolled in the smoking category and 237 patients enrolled in the second-hand smoke category. There was an overall positive correlation with the measured lifestyle factors and the ultrasound-measured variables in the group of individuals who smoked. For all variables, age seemed to contribute the most out of all of the lifestyle factors for the positive changes in CIMT and CCA wall stiffness. CONCLUSION: Our data yielded correlations between CCA properties and cardiovascular risk, as well as between CIMT and arterial stiffness. We were also able to demonstrate an increase in thickness of the CIMT in patients who have been exposed by tobacco through the use of ultrasound. Further large scale studies comparing patients with multiple cardiac risk factors need to be performed to confirm the utility of ultrasound findings of cardiovascular disease and stroke.

13.
Med Dosim ; 41(1): 15-21, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26235550

RESUMEN

The hippocampus is responsible for memory and cognitive function. An ongoing phase II clinical trial suggests that sparing dose to the hippocampus during whole-brain radiation therapy can help preserve a patient׳s neurocognitive function. Progressive research and advancements in treatment techniques have made treatment planning more sophisticated but beneficial for patients undergoing treatment. The aim of this study is to evaluate and compare hippocampal sparing whole-brain (HS-WB) radiation therapy treatment planning techniques using volume-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). We randomly selected 3 patients to compare different treatment techniques that could be used for reducing dose to the hippocampal region. We created 2 treatment plans, a VMAT and an IMRT, from each patient׳s data set and planned on the Eclipse 11.0 treatment planning system (TPS). A total of 6 plans (3 IMRT and 3 VMAT) were created and evaluated for this case study. The physician contoured the hippocampus as per the Radiation Therapy Oncology Group (RTOG) 0933 protocol atlas. The organs at risk (OR) were contoured and evaluated for the plan comparison, which included the spinal cord, optic chiasm, the right and left eyes, lenses, and optic nerves. Both treatment plans produced adequate coverage on the planning target volume (PTV) while significantly reducing dose to the hippocampal region. The VMAT treatment plans produced a more homogenous dose distribution throughout the PTV while decreasing the maximum point dose to the target. However, both treatment techniques demonstrated hippocampal sparing when irradiating the whole brain.


Asunto(s)
Neoplasias Encefálicas/radioterapia , Hipocampo , Tratamientos Conservadores del Órgano/métodos , Planificación de la Radioterapia Asistida por Computador/métodos , Neoplasias Encefálicas/secundario , Humanos , Radioterapia de Intensidad Modulada
14.
Hum Mol Genet ; 24(7): 1918-28, 2015 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-25510505

RESUMEN

Osteogenesis imperfecta (OI) is a genetic disorder that results in low bone mineral density and brittle bones. Most cases result from dominant mutations in the type I procollagen genes, but mutations in a growing number of genes have been identified that produce autosomal recessive forms of the disease. Among these include mutations in the genes SERPINH1 and FKBP10, which encode the type I procollagen chaperones HSP47 and FKBP65, respectively, and predominantly produce a moderately severe form of OI. Little is known about the biochemical consequences of the mutations and how they produce OI. We have identified a new OI mutation in SERPINH1 that results in destabilization and mislocalization of HSP47 and secondarily has similar effects on FKBP65. We found evidence that HSP47 and FKBP65 act cooperatively during posttranslational maturation of type I procollagen and that FKBP65 and HSP47 but fail to properly interact in mutant HSP47 cells. These results thus reveal a common cellular pathway in cases of OI caused by HSP47 and FKBP65 deficiency.


Asunto(s)
Colágeno Tipo I/biosíntesis , Proteínas del Choque Térmico HSP47/metabolismo , Osteogénesis Imperfecta/metabolismo , Procolágeno/biosíntesis , Proteínas de Unión a Tacrolimus/metabolismo , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Preescolar , Femenino , Proteínas del Choque Térmico HSP47/química , Proteínas del Choque Térmico HSP47/genética , Humanos , Masculino , Datos de Secuencia Molecular , Osteogénesis Imperfecta/genética , Linaje , Transporte de Proteínas , Alineación de Secuencia , Proteínas de Unión a Tacrolimus/química , Proteínas de Unión a Tacrolimus/genética , Adulto Joven
15.
Dalton Trans ; (36): 7481-5, 2009 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-19727470

RESUMEN

The synthesis and physical properties of the ternary complex 3(2+), prepared by reaction of a naphthalene diimide dicarboxylate 2 with the binucleating dinickel(II) cavitand 1, are discussed. The complex 3(2+) is characterised by cyclic voltammetry which shows a wealth of metal-centred and diimide-based processes at -1.62, -1.04 and 0.15 V vs Fc/Fc+. Absorption and fluorescence spectroscopy of 3(2+) in CH2Cl2 compared to the components 4+ and 5, respectively, are used to characterise the complex further. In particular there is a substantial quenching (approximately 95%) of the diimide fluorescence upon complexation. X-Ray crystallography has been used to characterise complex 3(2+) in the solid state. Of particular interest is the supramolecular structure in which the naphthalene diimide is included between the two metallocavitand hemispheres.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...